Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT) - final results from the GerHIT multi-centre registry study

被引：0
|
作者：
Schindewolf, M. [1 ]
Steindl, J. [1 ]
Beyer-Westendorf, J. [2 ]
Schellong, S. [3 ]
Dohmen, P. M. [4 ]
Brachmann, J. [5 ]
Madlener, K. [6 ]
Poetzsch, B. [7 ]
Klamroth, R. [8 ]
Lindhoff-Last, E. [1 ]
机构：
[1] Goethe Univ Hosp Frankfurt M, Frankfurt, Germany
[2] Univ Hosp Carl Gustav Carus, Dresden, Germany
[3] Municipal Hosp Dresden Friedrichstadt, Dresden, Germany
[4] Univ Leipzig, Heart Ctr Leipzig, D-04109 Leipzig, Germany
[5] Klinikum Coburg, Coburg, Germany
[6] Max Planck Inst Physiol & Clin Res, Kerckhoff Klin, Bad Nauheim, Germany
[7] Univ Hosp Bonn, Bonn, Germany
[8] Vivantes Klinikum Friedrichshain Berlin, Berlin, Germany
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：935 / 935
页数：1
相关论文
共 10 条
  • [1] Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT) - results from the GerHIT multi-centre registry study
    Schindewolf, M.
    Scheuermann, J.
    Beyer-Westendorf, J.
    Schellong, S.
    Dohmen, P.
    Brachmann, J.
    Madlener, K.
    Poetzsch, B.
    Klamroth, R.
    Hankowitz, J.
    Lengfelder, M.
    Banik, N.
    Eberle, S.
    Kropff, S.
    Mueller, M.
    Lindhoff-Last, E.
    INTERNIST, 2013, 54 : 11 - 11
  • [2] Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT) - findings from the GerHIT multi-centre registry study
    Schindewolf, Marc
    Steindl, Julia
    Beyer-Westendorf, Jan
    Schellong, Sebastian
    Dohmen, Pascal Maria
    Brachmann, Johannes
    Madlener, Katharina
    Poetzsch, Bernd
    Klamroth, Robert
    Hankowitz, Johannes
    Banik, Norbert
    Eberle, Sonja
    Kropff, Stefan
    Mueller, Markus Michael
    Lindhoff-Last, Edelgard
    THROMBOSIS RESEARCH, 2014, 134 (01) : 29 - 35
  • [3] Off-label use of fondaparinux in suspected acute heparin-induced thrombocytopenia (HIT) - final results from the GerHIT multicentre, retrospective registry study
    Schindewolf, M.
    Steindl, J.
    Beyer-Westendorf, J.
    Schellong, S.
    Dohmen, P. M.
    Brachmann, J.
    Madlener, K.
    Poetzsch, B.
    Klamroth, R.
    Lindhoff-Last, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 410 - 411
  • [4] Use of fondaparinux in suspected acute heparin-induced thrombocytopenia (HIT) - final results from the GerHIT multicentre registry study
    Schindewolf, M.
    Scheuermann, J.
    Beyer-Westendorf, J.
    Schellong, S.
    Dohmen, P.
    Brachmann, J.
    Madlener, K.
    Poetzsch, B.
    Klamroth, R.
    Hankowitz, J.
    Lengfelder, M.
    Banik, N.
    Eberle, S.
    Kropff, S.
    Mueller, M.
    Lindhoff-Last, E.
    INTERNIST, 2013, 54 : 11 - 11
  • [5] Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia
    Schindewolf, Marc
    Steindl, Julia
    Beyer-Westendorf, Jan
    Schellong, Sebastian
    Dohmen, Pascal Maria
    Brachmann, Johannes
    Madlener, Katharina
    Poetzsch, Bernd
    Klamroth, Robert
    Hankowitz, Johannes
    Banik, Norbert
    Eberle, Sonja
    Mueller, Markus Michael
    Kropff, Stefan
    Lindhoff-Last, Edelgard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (21) : 2636 - 2648
  • [6] Efficacy and Safety of Off-Label Use of Fondaparinux in the Management of Heparin-Induced Thrombocytopenia With Thrombosis in an Elderly Woman
    Leporini, Christian
    Rende, Antonio
    Sorrentino, Alfonso
    Rizzica, Elvira
    Russo, Emilio
    Gallelli, Luca
    De Sarro, Giovambattista
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (09): : 999 - 1002
  • [7] Fondaparinux versus lepirudin in the management of patients with suspected heparin-induced thrombocytopenia (HIT) with or without thrombosis (on behalf of the FLHIT study investigators)
    Piovella, F.
    Barone, M.
    Beltrametti, C.
    Piovella, C.
    Barco, S.
    De Amici, M.
    D'Angelo, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 458 - 458
  • [8] Rapid diagnosis of heparin-induced thrombocytopenia (HIT) by whole blood impedance aggregometry: results of the Australian multi centre study
    Morel-Kopp, M-C
    Tan, C. W.
    Brighton, T.
    McRae, S.
    Tran, H.
    Mollee, P.
    Kershaw, G.
    Joseph, J.
    Coyle, L.
    Ward, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 82 - 82
  • [9] A Randomized, Open-Label Pilot Study Comparing Desirudin and Argatroban in Patients With Suspected Heparin-Induced Thrombocytopenia With or Without Thrombosis: PREVENT-HIT Study
    Boyce, Steven W.
    Bandyk, Dennis F.
    Bartholomew, John R.
    Frame, James N.
    Rice, Lawrence
    AMERICAN JOURNAL OF THERAPEUTICS, 2011, 18 (01) : 14 - 22
  • [10] Rationale and Design of the PREVENT-HIT Study: A Randomized, Open-Label Pilot Study to Compare Desirudin and Argatroban in Patients With Suspected Heparin-Induced Thrombocytopenia With or Without Thrombosis
    Frame, James N.
    Rice, Lawrence
    Bartholomew, John R.
    Whelton, Andrew
    CLINICAL THERAPEUTICS, 2010, 32 (04) : 626 - 636
1